Quick Answer
Perspective Therapeutics, Inc. reported Gross Profit of $1.43 million for fiscal year 2023.
Perspective Therapeutics, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2023 | $1.43M | — |
| 2022 | $0.00 | — |
| 2022 | $0.00 | -100.0% |
| 2021 | $5.12M | -0.1% |
| 2020 | $5.12M | +68.2% |
| 2019 | $3.05M | +65.4% |
| 2018 | $1.84M | +119.8% |
| 2017 | $838.0K | +549.6% |
| 2016 | $129.0K | -22.8% |
| 2015 | $167.0K | +185.0% |
| 2014 | -$196.5K | -230.8% |
| 2013 | $150.2K | -78.6% |
| 2012 | $703.2K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $738.0K | +78.3% | +197.6% |
| June 30, 2023 | $248.0K | -73.2% | -49.1% |
| March 31, 2023 | $487.0K | -66.2% | +17.6% |
| September 30, 2022 | $414.0K | -59.8% | -55.3% |
| June 30, 2022 | $926.0K | — | -35.7% |
| March 31, 2022 | $1.44M | +5.8% | +18.1% |
| December 31, 2021 | $1.22M | +4.5% | +18.6% |
| September 30, 2021 | $1.03M | -17.4% | -24.4% |
- Over the 2012–2023 period, Perspective Therapeutics, Inc.’s gross profit has grown by 103.9% (from $703.2 thousand to $1.43 million).
- The most recent figure is from Perspective Therapeutics, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 28, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: